OptimizeRx Debt to Equity Ratio 2012-2025 | OPRX
Current and historical debt to equity ratio values for OptimizeRx (OPRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OptimizeRx debt/equity for the three months ending December 31, 2025 was 0.20.
| OptimizeRx Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $0.05B | $0.13B | 0.38 |
| 2025-09-30 | $0.05B | $0.12B | 0.39 |
| 2025-06-30 | $0.05B | $0.12B | 0.42 |
| 2025-03-31 | $0.05B | $0.12B | 0.44 |
| 2024-12-31 | $0.05B | $0.12B | 0.46 |
| 2024-09-30 | $0.05B | $0.11B | 0.44 |
| 2024-06-30 | $0.05B | $0.12B | 0.43 |
| 2024-03-31 | $0.05B | $0.12B | 0.44 |
| 2023-12-31 | $0.06B | $0.13B | 0.45 |
| 2023-09-30 | $0.01B | $0.12B | 0.07 |
| 2023-06-30 | $0.01B | $0.12B | 0.05 |
| 2023-03-31 | $0.01B | $0.12B | 0.06 |
| 2022-12-31 | $0.01B | $0.13B | 0.07 |
| 2022-09-30 | $0.01B | $0.13B | 0.05 |
| 2022-06-30 | $0.01B | $0.14B | 0.05 |
| 2022-03-31 | $0.01B | $0.13B | 0.05 |
| 2021-12-31 | $0.01B | $0.13B | 0.07 |
| 2021-09-30 | $0.01B | $0.13B | 0.06 |
| 2021-06-30 | $0.01B | $0.13B | 0.06 |
| 2021-03-31 | $0.01B | $0.12B | 0.05 |
| 2020-12-31 | $0.01B | $0.05B | 0.21 |
| 2020-09-30 | $0.01B | $0.05B | 0.18 |
| 2020-06-30 | $0.01B | $0.04B | 0.29 |
| 2020-03-31 | $0.01B | $0.04B | 0.29 |
| 2019-12-31 | $0.01B | $0.05B | 0.26 |
| 2019-09-30 | $0.01B | $0.04B | 0.18 |
| 2019-06-30 | $0.01B | $0.04B | 0.18 |
| 2019-03-31 | $0.01B | $0.02B | 0.30 |
| 2018-12-31 | $0.01B | $0.02B | 0.36 |
| 2018-09-30 | $0.00B | $0.02B | 0.15 |
| 2018-06-30 | $0.00B | $0.02B | 0.18 |
| 2018-03-31 | $0.00B | $0.01B | 0.36 |
| 2017-12-31 | $0.00B | $0.01B | 0.57 |
| 2017-09-30 | $0.00B | $0.01B | 0.62 |
| 2017-06-30 | $0.00B | $0.01B | 0.62 |
| 2017-03-31 | $0.00B | $0.01B | 0.55 |
| 2016-12-31 | $0.00B | $0.01B | 0.47 |
| 2016-09-30 | $0.00B | $0.01B | 0.40 |
| 2016-06-30 | $0.00B | $0.01B | 0.35 |
| 2016-03-31 | $0.00B | $0.01B | 0.30 |
| 2015-12-31 | $0.00B | $0.01B | 0.38 |
| 2015-09-30 | $0.00B | $0.01B | 0.33 |
| 2015-06-30 | $0.00B | $0.01B | 0.49 |
| 2015-03-31 | $0.00B | $0.01B | 0.48 |
| 2014-12-31 | $0.00B | $0.01B | 0.53 |
| 2014-09-30 | $0.00B | $0.01B | 0.31 |
| 2014-06-30 | $0.00B | $0.01B | 0.31 |
| 2014-03-31 | $0.00B | $0.01B | 0.42 |
| 2013-12-31 | $0.00B | $0.00B | 1.37 |
| 2013-09-30 | $0.00B | $0.00B | 0.37 |
| 2013-06-30 | $0.00B | $0.00B | 0.40 |
| 2013-03-31 | $0.00B | $0.00B | 0.54 |
| 2012-12-31 | $0.00B | $0.00B | 0.55 |
| 2012-09-30 | $0.00B | $0.00B | 0.67 |
| 2012-06-30 | $0.00B | $0.00B | 0.74 |
| 2012-03-31 | $0.00B | $0.00B | 0.67 |
| 2011-12-31 | $0.00B | $0.00B | 0.82 |
| 2011-09-30 | $0.00B | $0.00B | 0.39 |
| 2011-06-30 | $0.00B | $0.00B | 1.43 |
| 2011-03-31 | $0.00B | $0.00B | 1.12 |
| 2010-12-31 | $0.00B | $0.00B | 0.98 |
| 2010-09-30 | $0.00B | $0.00B | 0.44 |
| 2010-06-30 | $0.00B | $0.00B | 0.34 |
| 2010-03-31 | $0.00B | $0.00B | 0.02 |
| 2009-12-31 | $0.00B | $0.00B | 0.04 |
| 2009-09-30 | $0.00B | $0.00B | 0.01 |
| 2009-06-30 | $0.00B | $0.00B | 0.03 |
| 2009-03-31 | $0.00B | $0.00B | 0.11 |
| 2008-12-31 | $0.00B | $0.00B | 0.09 |
| 2008-09-30 | $0.00B | $0.00B | 0.00 |
| 2008-06-30 | $0.00B | 0.00 | |
| 2008-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Computer Software | $0.163B | $0.092B |
| OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microsoft (MSFT) | United States | $2980.054B | 26.09 |
| Oracle (ORCL) | United States | $460.103B | 28.19 |
| SAP SE (SAP) | Germany | $251.266B | 29.39 |
| Salesforce (CRM) | United States | $177.768B | 20.87 |
| Intuit (INTU) | United States | $111.143B | 24.82 |
| Adobe (ADBE) | United States | $108.360B | 15.33 |
| Synopsys (SNPS) | United States | $83.623B | 48.35 |
| Cadence Design Systems (CDNS) | United States | $81.513B | 55.35 |
| Dassault Systemes SA (DASTY) | France | $28.215B | 16.05 |
| PTC (PTC) | United States | $18.655B | 21.04 |
| SS&C Technologies Holdings (SSNC) | United States | $17.592B | 13.38 |
| Manhattan Associates (MANH) | United States | $8.406B | 39.56 |
| Pegasystems (PEGA) | United States | $7.413B | 32.01 |
| Open Text (OTEX) | Canada | $6.162B | 6.66 |
| Descartes Systems Group (DSGX) | Canada | $5.655B | 37.14 |
| Trend Micro (TMICY) | Japan | $5.095B | 20.32 |
| ACI Worldwide (ACIW) | United States | $4.078B | 15.16 |
| CommVault Systems (CVLT) | United States | $3.853B | 37.45 |
| Sapiens (SPNS) | Israel | $2.433B | 31.04 |
| Blackbaud (BLKB) | United States | $2.348B | 17.22 |
| Progress Software (PRGS) | United States | $1.538B | 7.94 |
| PROS Holdings (PRO) | United States | $1.123B | 0.00 |
| Rand Worldwide (RWWI) | United States | $0.538B | 0.00 |
| Simulations Plus (SLP) | United States | $0.248B | 12.41 |
| NetSol Technologies (NTWK) | United States | $0.038B | 20.19 |
| Neonode (NEON) | Sweden | $0.029B | 0.00 |
| Wetouch Technology (WETH) | China | $0.020B | 2.73 |
| Smith Micro Software (SMSI) | United States | $0.012B | 0.00 |
| Global Interactive Technologies (GITS) | South Korea | $0.008B | 0.00 |
| Magic Software Enterprises (MGIC) | Israel | $0.000B | 18.90 |